High performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids

G. E. Davis, R. D. Suits, K. C. Kuo, C. W. Gehrke, T. P. Waalkes, E. Borek

Research output: Contribution to journalArticle

Abstract

Precise, quantitative high-performance liquid chromatography of samples equivalent to 25 μl of urine can be done in less than 1 hr with excellent resolution and recovery of pseudouridine, 1-methyladenosine, 1-methylinosine, N 2-methylguanosine, adenosine, and N 2,N 2-dimethyl-guanosine. These six nucleosides are present in normal urine in concentrations ranging from 0.4 to 60 mg/liter. The use of an affinity chromatograph column with a bound boronic acid functionality has enabled them to retain nucleosides selectively as boronate complexes from biological samples as complex as urine. The nucleosides are readily eluted with dilute formic acid from the boronate affinity column, concentrated, and separated by reversed-phase liquid chromatography on 'μ Bondapak/C 18' columns. In addition, about 10 other nucleosides are resolved and present in normal urine, 0.2 to 4 mg/liter. Isocratic chromatographic quantitation gave a minimum detection limit of 5 pmol or less for each of the nine nucleosides examined; the relation between peak area and concentration was linear with average CV's of less than 3% for six nucleosides over the range of 100 to 1000 pmol for each nucleoside injected. Analytical recoveries of nucleosides from standard mixtures exceeded 90% at concentrations comparable to those found in normal urine; those for eight nucleosides added to urine exceeded 85% at a concentration of 5 nmol (about 1 μg) added per milliliter. The method is being used to determine the concentrations, and their ratios (to creatinine), of nucleosides in urine from patients with different types of cancer. Data on urine samples from normal persons and persons with cancer of the colon are compared by gas chromatography and the present method. Application of the method to serum and amniotic fluid is demonstrated.

Original languageEnglish (US)
Pages (from-to)1427-1435
Number of pages9
JournalClinical Chemistry
Volume23
Issue number8
StatePublished - 1977
Externally publishedYes

Fingerprint

Nucleosides
Urine
Fluids
Liquids
formic acid
Pseudouridine
Boronic Acids
Recovery
Guanosine
Liquid chromatography
High performance liquid chromatography
Reverse-Phase Chromatography
Amniotic Fluid
Gas chromatography
Gas Chromatography
Adenosine
Colonic Neoplasms
Limit of Detection
Creatinine
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Davis, G. E., Suits, R. D., Kuo, K. C., Gehrke, C. W., Waalkes, T. P., & Borek, E. (1977). High performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids. Clinical Chemistry, 23(8), 1427-1435.

High performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids. / Davis, G. E.; Suits, R. D.; Kuo, K. C.; Gehrke, C. W.; Waalkes, T. P.; Borek, E.

In: Clinical Chemistry, Vol. 23, No. 8, 1977, p. 1427-1435.

Research output: Contribution to journalArticle

Davis, GE, Suits, RD, Kuo, KC, Gehrke, CW, Waalkes, TP & Borek, E 1977, 'High performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids', Clinical Chemistry, vol. 23, no. 8, pp. 1427-1435.
Davis, G. E. ; Suits, R. D. ; Kuo, K. C. ; Gehrke, C. W. ; Waalkes, T. P. ; Borek, E. / High performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids. In: Clinical Chemistry. 1977 ; Vol. 23, No. 8. pp. 1427-1435.
@article{862d0afbca7d4183bc86f79d47668483,
title = "High performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids",
abstract = "Precise, quantitative high-performance liquid chromatography of samples equivalent to 25 μl of urine can be done in less than 1 hr with excellent resolution and recovery of pseudouridine, 1-methyladenosine, 1-methylinosine, N 2-methylguanosine, adenosine, and N 2,N 2-dimethyl-guanosine. These six nucleosides are present in normal urine in concentrations ranging from 0.4 to 60 mg/liter. The use of an affinity chromatograph column with a bound boronic acid functionality has enabled them to retain nucleosides selectively as boronate complexes from biological samples as complex as urine. The nucleosides are readily eluted with dilute formic acid from the boronate affinity column, concentrated, and separated by reversed-phase liquid chromatography on 'μ Bondapak/C 18' columns. In addition, about 10 other nucleosides are resolved and present in normal urine, 0.2 to 4 mg/liter. Isocratic chromatographic quantitation gave a minimum detection limit of 5 pmol or less for each of the nine nucleosides examined; the relation between peak area and concentration was linear with average CV's of less than 3{\%} for six nucleosides over the range of 100 to 1000 pmol for each nucleoside injected. Analytical recoveries of nucleosides from standard mixtures exceeded 90{\%} at concentrations comparable to those found in normal urine; those for eight nucleosides added to urine exceeded 85{\%} at a concentration of 5 nmol (about 1 μg) added per milliliter. The method is being used to determine the concentrations, and their ratios (to creatinine), of nucleosides in urine from patients with different types of cancer. Data on urine samples from normal persons and persons with cancer of the colon are compared by gas chromatography and the present method. Application of the method to serum and amniotic fluid is demonstrated.",
author = "Davis, {G. E.} and Suits, {R. D.} and Kuo, {K. C.} and Gehrke, {C. W.} and Waalkes, {T. P.} and E. Borek",
year = "1977",
language = "English (US)",
volume = "23",
pages = "1427--1435",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "8",

}

TY - JOUR

T1 - High performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids

AU - Davis, G. E.

AU - Suits, R. D.

AU - Kuo, K. C.

AU - Gehrke, C. W.

AU - Waalkes, T. P.

AU - Borek, E.

PY - 1977

Y1 - 1977

N2 - Precise, quantitative high-performance liquid chromatography of samples equivalent to 25 μl of urine can be done in less than 1 hr with excellent resolution and recovery of pseudouridine, 1-methyladenosine, 1-methylinosine, N 2-methylguanosine, adenosine, and N 2,N 2-dimethyl-guanosine. These six nucleosides are present in normal urine in concentrations ranging from 0.4 to 60 mg/liter. The use of an affinity chromatograph column with a bound boronic acid functionality has enabled them to retain nucleosides selectively as boronate complexes from biological samples as complex as urine. The nucleosides are readily eluted with dilute formic acid from the boronate affinity column, concentrated, and separated by reversed-phase liquid chromatography on 'μ Bondapak/C 18' columns. In addition, about 10 other nucleosides are resolved and present in normal urine, 0.2 to 4 mg/liter. Isocratic chromatographic quantitation gave a minimum detection limit of 5 pmol or less for each of the nine nucleosides examined; the relation between peak area and concentration was linear with average CV's of less than 3% for six nucleosides over the range of 100 to 1000 pmol for each nucleoside injected. Analytical recoveries of nucleosides from standard mixtures exceeded 90% at concentrations comparable to those found in normal urine; those for eight nucleosides added to urine exceeded 85% at a concentration of 5 nmol (about 1 μg) added per milliliter. The method is being used to determine the concentrations, and their ratios (to creatinine), of nucleosides in urine from patients with different types of cancer. Data on urine samples from normal persons and persons with cancer of the colon are compared by gas chromatography and the present method. Application of the method to serum and amniotic fluid is demonstrated.

AB - Precise, quantitative high-performance liquid chromatography of samples equivalent to 25 μl of urine can be done in less than 1 hr with excellent resolution and recovery of pseudouridine, 1-methyladenosine, 1-methylinosine, N 2-methylguanosine, adenosine, and N 2,N 2-dimethyl-guanosine. These six nucleosides are present in normal urine in concentrations ranging from 0.4 to 60 mg/liter. The use of an affinity chromatograph column with a bound boronic acid functionality has enabled them to retain nucleosides selectively as boronate complexes from biological samples as complex as urine. The nucleosides are readily eluted with dilute formic acid from the boronate affinity column, concentrated, and separated by reversed-phase liquid chromatography on 'μ Bondapak/C 18' columns. In addition, about 10 other nucleosides are resolved and present in normal urine, 0.2 to 4 mg/liter. Isocratic chromatographic quantitation gave a minimum detection limit of 5 pmol or less for each of the nine nucleosides examined; the relation between peak area and concentration was linear with average CV's of less than 3% for six nucleosides over the range of 100 to 1000 pmol for each nucleoside injected. Analytical recoveries of nucleosides from standard mixtures exceeded 90% at concentrations comparable to those found in normal urine; those for eight nucleosides added to urine exceeded 85% at a concentration of 5 nmol (about 1 μg) added per milliliter. The method is being used to determine the concentrations, and their ratios (to creatinine), of nucleosides in urine from patients with different types of cancer. Data on urine samples from normal persons and persons with cancer of the colon are compared by gas chromatography and the present method. Application of the method to serum and amniotic fluid is demonstrated.

UR - http://www.scopus.com/inward/record.url?scp=0017648138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017648138&partnerID=8YFLogxK

M3 - Article

C2 - 872405

AN - SCOPUS:0017648138

VL - 23

SP - 1427

EP - 1435

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 8

ER -